Skip to main content
BNR logo
BNR
(NASDAQ)
Burning Rock Biotech Limited
$16.20-- (--)
Loading... - Market loading

Burning Rock Biotech (BNR) Stock Price & Financial Analysis

Burning Rock Biotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.20 - $17.05
52-Week High$41.72
52-Week Low$2.18
Open$16.79
Volume55.94K
Average Volume (3M)55.94K
Market Cap174.54M
Shares Outstanding10.77M
Price to Sales (P/S)2.24
Price to Book (P/B)2.20
EV/EBITDA-8.30
Revenue (TTM)78.34M
Net Income (TTM)-17.61M
Free Cash Flow (TTM)-5.49M
EPS (TTM)$-1.63
Profit Margin-22.48%
Operating Margin-16.62%
Return on Equity (ROE)-22.06%
Debt to Equity0.00
50-Day MA$26.17
200-Day MA$15.20
52-Week Change275.58%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Burning Rock Biotech

What is the current stock price for BNR?

As of the latest trading session, BNR stock trades at $16.20. The 52-week range is $2.18–$41.72, with a day range of $16.20–$17.05.

What is the P/E ratio for BNR?

The P/E ratio (Price-to-Earnings) for BNR is shown in the Key Statistics section. This valuation metric helps compare Burning Rock Biotech Limited to industry peers.

Does BNR pay dividends?

Burning Rock Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BNR?

Analyst ratings and recommendations for BNR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BNR?

Burning Rock Biotech's market capitalization is $174.5M, classifying it as a micro-cap company. Burning Rock Biotech operates in the Healthcare sector within the Diagnostics & Research industry.